Clarus Lifesciences II, L.P.'s Net Worth
$16.8 Million
Who is Clarus Lifesciences II, L.P.?
Clarus Lifesciences II, L.P. has an estimated net worth of $16.8 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, AERIE PHARMACEUTICALS INC, Ophthotech Corp., Restoration Robotics Inc, ACHILLION PHARMACEUTICALS INC, NanoString Technologies Inc, and CATABASIS PHARMACEUTICALS INC.
SEC CIK
Clarus Lifesciences II, L.P.'s CIK is 0001431443
Past Insider Trading and Trends
2013 was Clarus Lifesciences II, L.P.'s most active year for acquiring shares with 17 total transactions. Clarus Lifesciences II, L.P.'s most active month to acquire stocks was the month of September. 2013 was Clarus Lifesciences II, L.P.'s most active year for disposing of shares, totalling 13 transactions. Clarus Lifesciences II, L.P.'s most active month to dispose stocks was the month of December. 2013 saw Clarus Lifesciences II, L.P. paying a total of $31,399,997.22 for 15,654,071 shares, this is the most they've acquired in one year. In 2015 Clarus Lifesciences II, L.P. cashed out on 35,421,782 shares for a total of $6,173,163.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRALOGIC PHARMACEUTICALS Corp No price found
InvestorClarus Lifesciences II, L.P. owns 2,214,523 units of Common Stock.acquired a total of 4,644,705 shares in TETRALOGIC PHARMACEUTICALS Corp at a cost of $16,098,409.02, Clarus also disposed a total of 2,430,182 shares of TETRALOGIC PHARMACEUTICALS Corp equalling to $463,127.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.09% | -333.63K |
$0.17 | -$56,474.49 | 2.21M |
Feb 8 - Feb 9
| |||
Form 4
| -35.71% | -1.42M |
$0.18 | -$248,967.29 | 2.55M |
Feb 3 - Feb 5
| |||
Form 4
| -8.52% | -369.13K |
$0.19 | -$71,706.78 | 3.96M |
Jan 29 - Feb 2
| |||
Form 4
| -6.72% | -311.93K |
$0.28 | -$85,978.64 | 4.33M |
Jan 26 - Jan 28
| |||
Form 4
|
∞
| 4.64M |
$6.99 |
—
| 4.64M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AERIE PHARMACEUTICALS INC No price found
InvestorClarus Lifesciences II, L.P. used to own units in Common Stock but no longer holds any shares there. In the year 2013 Clarus Lifesciences II, L.P. filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.14M |
—
|
—
|
0
|
Jan 28
| |||
Form 4/A
| +10.20% | 321K |
$10.00 | $3,210,000.00 | 3.47M |
Oct 25
| |||
Form 4
| -5.00% | -175.00K |
$31.11 | -$5,444,250.00 | 3.32M |
Jan 8
| |||
Form 4
| -0.67% | -23.62K |
$30.86 | -$728,913.40 | 3.5M |
Jan 5
| |||
Form 4
| -2.24% | -80.72K |
$30.05 | -$2,425,631.92 | 3.52M |
Dec 26 - Dec 29
| |||
Form 4
| -1.36% | -49.70K |
$30.36 | -$1,508,918.76 | 3.6M |
Dec 22 - Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 3.65M |
$6.36 |
—
| 3.65M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ophthotech Corp. No price found
InvestorClarus Lifesciences II, L.P. used to own units in Common Stock but no longer holds any shares there. In the year 2013 Clarus Lifesciences II, L.P. filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.55M |
—
|
—
|
0
|
May 26
| |||
Form 4
| -6.92% | -211.68K |
$44.87 | -$9,614,174.25 | 2.85M |
Jun 9 - Jun 11
| |||
Form 4
| +107.32% | 2.73M |
—
|
—
| 5.27M |
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Restoration Robotics Inc (VERO) Snapshot price: $0.53
InvestorClarus Lifesciences II, L.P. owns 3,569,986 units of Common Stock which is worth $1,892,092.58. In the year 2017 Clarus Lifesciences II, L.P. filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.57M |
$7.00 |
—
| 3.57M |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.94M |
—
|
—
| 3 |
Jun 4
| |||
Form 4
| +18.14% | 1.68M |
$5.39 | -$9.11 | 10.94M |
May 31
| |||
Form 4
| +111.15% | 4.88M |
$2.49 | $12,139,999.98 | 9.26M |
Aug 20
| |||
Form 4
| -5.06% | -233.99K |
$3.77 | -$881,370.13 | 4.39M |
Scheduled
|
Jan 11
| ||
Form 4
| -1.13% | -53.00K |
$3.50 | -$185,633.38 | 4.62M |
Scheduled
|
Jan 6 - Jan 7
| ||
Form 4
| -0.08% | -3.60K |
$3.53 | -$12,695.04 | 4.67M |
Scheduled
|
Dec 24
| ||
Form 4
| -5.72% | -284.00K |
$3.69 | -$1,049,091.67 | 4.68M |
Scheduled
|
Dec 21 - Dec 23
| ||
Form 4
| -4.01% | -207.18K |
$3.53 | -$730,323.04 | 4.96M |
Scheduled
|
Dec 16 - Dec 18
| ||
Form 4
| +0.09% | 4.65K |
$2.25 | $10,484.49 | 5.31M |
Sep 5 - Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||